A washout is a waiting period during which a drug or substance clears from the body before something new begins. The term shows up most often in two settings: clinical research, where it prevents one treatment from interfering with the next, and medical imaging, where it describes how quickly contrast dye leaves a tissue. Both uses share the same core idea, the clearing out of one thing so you can get an accurate read on what comes next.
Washout in Clinical Trials
In research, a washout period is a drug-free gap built into a study’s design. Participants stop taking a medication (or sometimes all medications for the condition being studied) and wait until the drug has left their system before starting the next phase of the trial. The goal is to create a clean baseline so that any effects observed afterward can be attributed to the new treatment, not leftover traces of the old one.
This matters most in crossover trials, where the same group of people tries two or more treatments in sequence. Without a washout between rounds, the first drug could still be active when the second one starts. Researchers call this a “carryover effect,” and it can make it impossible to tell which treatment actually caused the result. The washout can be passive, meaning the person simply takes nothing, or active, meaning they receive a neutral treatment while waiting for the previous drug to clear.
Washout periods also appear in observational studies that use health insurance claims data. Researchers look back through a patient’s records for a window of time, often 6 to 12 months, to confirm the person wasn’t already taking the medication being studied. This ensures they’re looking at new users rather than people who’ve been on a drug for years, which could skew the results.
How Long a Washout Takes
The standard rule is five half-lives. A drug’s half-life is the time it takes for half of it to leave your bloodstream. After one half-life, 50% remains. After two, 25%. By the time five half-lives have passed, 94% to 97% of the drug is gone, and it’s considered effectively eliminated.
For most common antidepressants in the SSRI class, five half-lives works out to roughly five days. Fluoxetine is the major exception. It produces an active byproduct that lingers in the body far longer, so a washout after stopping fluoxetine typically runs four to seven days for straightforward switches, but stretches to five or six weeks when switching to certain older antidepressant classes that could dangerously interact with any remaining fluoxetine. Going the other direction, stopping an older irreversible antidepressant before starting most newer ones requires a two- to three-week washout.
These timelines vary by drug, dose, and individual metabolism. A shorter “moderate” washout of two to four days is sometimes used when a longer gap would leave a patient without treatment for too long, though it carries slightly more risk of drug overlap.
Risks of Going Without Treatment
Washout periods create a real tension in clinical research. During the gap, participants are off effective therapy, and their condition can worsen. This is especially concerning in trials that assign some participants to a placebo afterward, meaning they may go weeks or months without active treatment.
Ethical guidelines require that washout periods are only used when there’s a strong scientific reason for them and participants won’t face serious or irreversible harm. People at higher risk of deteriorating are typically excluded. Informed consent must spell out the risks clearly, including the possibility that symptoms will get worse, and there should be a plan to end the washout early and restart treatment if a participant’s health declines.
Washout in Medical Imaging
In radiology, washout refers to something different: the speed at which contrast dye fades from a piece of tissue after being injected. During a CT or ultrasound exam, a contrast agent highlights blood flow through organs. Doctors then watch how quickly the contrast disappears from a mass or lesion over the following minutes. The rate of that disappearance is the washout.
This is particularly useful for evaluating liver and adrenal masses. Malignant liver tumors generally have a lower blood volume than the surrounding healthy liver tissue. So on contrast-enhanced ultrasound, most malignant nodules show washout, meaning they lose their contrast enhancement faster or more completely than the normal liver around them. The timing and degree of washout help distinguish different types of cancer from benign growths. Benign lesions like certain common liver nodules tend to hold onto contrast longer because of their richer blood supply.
Adrenal Washout Thresholds
For adrenal gland masses found incidentally on a CT scan, washout percentages serve as a key diagnostic tool. Radiologists measure how much contrast has left the mass at a delayed time point and calculate a percentage. The commonly applied cutoffs are 60% for absolute washout and 40% for relative washout. A benign adrenal mass (usually a fat-rich adenoma) typically washes out quickly and clears these thresholds, while a malignant mass holds onto contrast and falls below them. Combining washout data with the initial density of the mass on a non-contrast scan pushes diagnostic accuracy above 90%.
The Common Thread
Whether the context is a clinical trial, a medication switch, or a CT scan, washout describes the process of something leaving the system so that what comes next can be measured or managed cleanly. In research, it protects the integrity of the data. In medication changes, it protects the patient from dangerous drug interactions. In imaging, it provides a visual signature that helps distinguish harmless masses from potentially dangerous ones. The word means the same thing in each case: clearing out, so you can see clearly.